Business · 21/02/2017
FDA Establishes Public Docket for Pediatric Postmarketing Pharmacovigilance and Drug Utilization Reviews
The FDA is seeking public comments on the pediatric postmarketing pharmacovigilance and drug utilization reviews of certain products, which were posted online between September 17, 2016, and February 24, 2017, and will not be discussed at an upcoming committee meeting.